#Winnonlin software

Where Is Our Strategic Focus? We provide tools and services that help our customers increase drug development efficiency, with a particular focus on the decisions occurring within the FDAвЂ™s вЂњcritical path.вЂќ 5000 250 5 1 Discovery Pre-Clinical Clinical Approval $23B 1 Dimasi, et al, 'The price of innovation: new estimates of drug development costs,' Journal of Health Economics, 22:2, March 2PAREXEL R&D Statistical Sourcebook from Bain and In VEstimated Global Pharma and Biotech R&D Spending by Category: BioPharm International, March 2003 4 PhRMA 2003 Industry Profile, March 2003 $48B The Critical Path except where noted all numbers are estimates for industry totals per year 3,4 Average time and cost per approved compound:8 years and $524M 1,2 Who Are Pharsight Customers? This is a sample from Pharsight's customer base which includes all Top 50 Pharmaceutical companies.

#Winnonlin software

Outsource PK/PD Analysis and Clinical Study Report Writing Training A variety of courses teaching Pharsight software tools and model-based drug development skills. Understand the competitive landscape PK/PD Reporting and Analysis Services (RAS) High quality NCA, Population PK/PD Analysis and Reporting. Quantify your decision-making Metadata Modeling-ready data sets complied by experts from public source medical & scientific literature. Improve productivity and compliance Strategic Consulting Services (SCS) Consulting expertise in model-based drug development and decision-making. What Are Pharsight Capabilities? One theme: Efficient Drug Development Software Enterprise and desktop products for analyzing, presenting and storing drug development data. Reimer, PhD Senior Director Reporting and Analysis Services Pharsight Corporation PK/PD Reporting and Analysis Services (RAS) January 2009 Mark L.J.